Nikkei Inc. and AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) jointly held the First Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC).

Working groups (WG) were established under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) in order to discuss the state of the antimicrobial market.

At this first meeting of WG1, WG1 members shared their perspectives on and global practices about pull incentives.

On the basis of WG discussions, participants agreed to join the second sub-committee on AMR and continue to work hard toward the eventual formulation of a concrete proposal on ways to incentivize antimicrobial R&D in the future.

In light of the situation with novel coronavirus, this meeting was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.

■Overview
Date and time: Wednesday, March 11, 2020
Organizer: AMR Alliance Japan (Secretariat: HGPI)

■Discussion
WG1 Members (alphabetical order by last name):
Yusuke Ariyoshi (Director, Healthcare Policy, Government Affairs Dept., Shionogi & Co., Ltd.)
Masashi Kawata (Senior Manager, Public Affairs & Policy, Corporate Affairs, Health & Value, Pfizer Japan Inc.)
Shoji Miyagawa (Director, Division of Infectious Disease Research, The Japan Agency for Medical Research and Development (AMED))
Akio Ozaki (Director, Public and Industry Policy, Health Policy, MSD K. K.)
Yasunori Tawaragi (Director, International Affairs, Japan Pharmaceutical Manufacturers Association)

Moderator:
Joji Sugawara (AMR Alliance Japan Secretariat/Senior Associate, HGPI)

Secretariat (alphabetical order by last name):
Matt McEnany (AMR Alliance Japan Secretariat/Manager, HGPI)
Tomohito Shibata (AMR Alliance Japan Secretariat/Senior Associate, HGPI)
Chiaki Toma (The Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) Project, Nikkei Inc.)
Mio Wakasa (The Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) Project, Nikkei Inc.)

 

■Related events held as part of the “The Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)” project in and after FY2019 (chronological order)

January 22, 2020 The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)